Andrea Laurenzi
Overview
Explore the profile of Andrea Laurenzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
791
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giorgino F, Bonfanti R, Castaldo F, Irace C, Laurenzi A, Maffeis C, et al.
J Diabetes Sci Technol
. 2025 Feb;
:19322968251316577.
PMID: 39927665
Background: Smart systems for multiple daily injections (Smart MDI) integrate continuous glucose monitoring, connected insulin pens, smartphone apps, and cloud-based data storage to provide bolus and corrective dose suggestions, reminders/alerts,...
2.
Caretto A, Di Terlizzi G, Pedone E, Pennella R, De Cobelli F, Tresoldi M, et al.
Acta Diabetol
. 2024 Nov;
PMID: 39611869
Aims: To investigate possible associations of glucose patterns with outcomes of Corona Virus Disease 19 (COVID-19) using continuous glucose monitoring (CGM) in 43 patients hospitalized for COVID-19 mild-to-moderate pneumonia, regardless...
3.
Serenari M, Lenzi J, Ricci C, Odaldi F, Maroni L, Laurenzi A, et al.
J Surg Res
. 2024 Feb;
296:441-446.
PMID: 38320363
Introduction: The multiorgan procurement (MOP) represents a chance for the general surgery resident to learn the fundamental steps of open abdominal surgery. The objective of this study was to evaluate...
4.
Dajti G, Germinario G, Prosperi E, Siniscalchi A, Vasuri F, Valente S, et al.
Artif Organs
. 2024 Jan;
48(6):619-625.
PMID: 38270476
Aim: The aim of the study was to identify predictors of early tumor recurrence in patients with hepatocellular carcinoma (HCC) after liver transplantation (LT). Methods: Retrospective cohort study in 237...
5.
Dasari B, Raptis D, Syn N, Serrablo A, Ramia J, Laurenzi A, et al.
BJS Open
. 2023 Sep;
7(5).
PMID: 37738617
Background: Bilobar liver metastases from colorectal cancer pose a challenge for obtaining a satisfactory oncological outcome with an adequate future liver remnant. This study aimed to assess the clinical and...
6.
Radi G, Ruffolo C, Laurenzi A
Front Oncol
. 2023 Aug;
13:1242530.
PMID: 37546406
No abstract available.
7.
Laurenzi A, Brandi G, Greco F, Prosperi E, Palloni A, Serenari M, et al.
Langenbecks Arch Surg
. 2023 Feb;
408(1):102.
PMID: 36826620
Introduction: The incidence of cholangiocarinoma (CCA), as well as the related mortality rate, has progressively increased over the last decades. Nevertheless improvement in patient management, diagnosis and therapies, recurrence rate...
8.
Carrera P, Marzinotto I, Bonfanti R, Massimino L, Calzavara S, Favellato M, et al.
Diabetologia
. 2023 Jan;
66(4):695-708.
PMID: 36692510
Aims/hypothesis: Islet autoantibodies (AAbs) are detected in >90% of individuals with clinically suspected type 1 diabetes at disease onset. A single AAb, sometimes at low titre, is often detected in...
9.
Tringali A, Milluzzo S, Ardito F, Laurenzi A, Ettorre G, Barbaro B, et al.
Ther Adv Gastrointest Endosc
. 2022 Dec;
15:26317745221139735.
PMID: 36465430
Intraductal biliary lesions can involve the main hepatic confluence. Assessment of the extension of pedunculated biliary lesions during per-oral cholangioscopy (POCS) can optimize and personalize the surgical strategy. Four consecutive...
10.
Pitocco D, Laurenzi A, Tomaselli L, Assaloni R, Consoli A, Bartolo P, et al.
Nutr Metab Cardiovasc Dis
. 2022 Aug;
32(10):2392-2398.
PMID: 35970683
Background And Aim: The use of technology offers recognized benefits to persons with diabetes. The aim of this study was to evaluate the organization of healthcare facilities, the composition of...